Conference item

Safety, immunogenicity, and efficacy results of a phase II trial of therapeutic vaccines for chronic HBV in the Gambia.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

McConkey, S., Awi, D., Cavenaugh, J., Mendy, M., Schneider, J., Pearse, G., & Hill, A. (2004). Safety, immunogenicity, and efficacy results of a phase II trial of therapeutic vaccines for chronic HBV in the Gambia. 40(4), 676A–676A.

MLA Style

McConkey, S, et al. “Safety, Immunogenicity, and Efficacy Results of a Phase II Trial of Therapeutic Vaccines for Chronic HBV in the Gambia.” vol. 40, no. 4, 2004, pp. 676A–676A.

Chicago Style

McConkey, S, D Awi, J Cavenaugh, et al. 2004. “Safety, Immunogenicity, and Efficacy Results of a Phase II Trial of Therapeutic Vaccines for Chronic HBV in the Gambia.” 40 (4): 676A–676A.
Print

Authors

+ McConkey, S More by this author

Role:: Author

+ Awi, D More by this author

Role:: Author

+ Cavenaugh, J More by this author

Role:: Author

+ Mendy, M More by this author

Role:: Author

+ Schneider, J More by this author

Role:: Author

More authors...

Host title:: HEPATOLOGY
Volume:: 40
Issue:: 4
Pages:: 676A-676A
Publication date:: 2004-10-01
ISSN:: 0270-9139

Pubs id:: pubs:95361
UUID:: uuid:213c461d-3455-4d70-8d60-27b98aaa0d88
Local pid:: pubs:95361
Source identifiers:: 95361
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_213c461d34554d708d6027b98aaa0d88

Terms of use

Copyright date:: 2004

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP